annual CFF:
$253.89M+$121.36M(+91.57%)Summary
- As of today (July 7, 2025), WVE annual cash flow from financing activities is $253.89 million, with the most recent change of +$121.36 million (+91.57%) on December 31, 2024.
- During the last 3 years, WVE annual CFF has risen by +$198.06 million (+354.77%).
- WVE annual CFF is now at all-time high.
Performance
WVE Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$4.16M-$30.83M(-88.12%)Summary
- As of today (July 7, 2025), WVE quarterly cash flow from financing activities is $4.16 million, with the most recent change of -$30.83 million (-88.12%) on March 31, 2025.
- Over the past year, WVE quarterly CFF has dropped by -$10.36 million (-71.36%).
- WVE quarterly CFF is now -97.96% below its all-time high of $203.75 million, reached on September 30, 2024.
Performance
WVE quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$243.53M-$10.36M(-4.08%)Summary
- As of today (July 7, 2025), WVE TTM cash flow from financing activities is $243.53 million, with the most recent change of -$10.36 million (-4.08%) on March 31, 2025.
- Over the past year, WVE TTM CFF has increased by +$131.54 million (+117.46%).
- WVE TTM CFF is now -22.16% below its all-time high of $312.87 million, reached on September 30, 2024.
Performance
WVE TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
WVE Cash from financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +91.6% | -71.4% | +117.5% |
3 y3 years | +354.8% | +215.7% | +402.1% |
5 y5 years | +54.4% | +576.7% | +1772.5% |
WVE Cash from financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +354.8% | -98.0% | >+9999.0% | -22.2% | +558.7% |
5 y | 5-year | at high | +354.8% | -98.0% | >+9999.0% | -22.2% | +1772.5% |
alltime | all time | at high | +6814.2% | -98.0% | +2746.5% | -22.2% | >+9999.0% |
WVE Cash from financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $4.16M(-88.1%) | $243.53M(-4.1%) |
Dec 2024 | $253.89M(+91.6%) | $34.98M(-82.8%) | $253.89M(-18.9%) |
Sep 2024 | - | $203.75M(>+9900.0%) | $312.87M(+182.4%) |
Jun 2024 | - | $653.00K(-95.5%) | $110.80M(-1.1%) |
Mar 2024 | - | $14.51M(-84.6%) | $111.99M(-15.5%) |
Dec 2023 | $132.53M(+97.3%) | $93.96M(+5526.5%) | $132.53M(+243.1%) |
Sep 2023 | - | $1.67M(-9.7%) | $38.63M(+4.5%) |
Jun 2023 | - | $1.85M(-94.7%) | $36.97M(-63.4%) |
Mar 2023 | - | $35.05M(>+9900.0%) | $100.92M(+50.2%) |
Dec 2022 | $67.19M(+20.3%) | $55.00K(+223.5%) | $67.19M(-33.4%) |
Sep 2022 | - | $17.00K(-100.0%) | $100.93M(-7.6%) |
Jun 2022 | - | $65.80M(+4900.0%) | $109.26M(+125.3%) |
Mar 2022 | - | $1.32M(-96.1%) | $48.50M(-13.1%) |
Dec 2021 | $55.83M(-63.9%) | $33.79M(+304.8%) | $55.83M(+153.1%) |
Sep 2021 | - | $8.35M(+65.5%) | $22.05M(-85.9%) |
Jun 2021 | - | $5.04M(-41.6%) | $156.23M(-3.9%) |
Mar 2021 | - | $8.64M(>+9900.0%) | $162.56M(+5.2%) |
Dec 2020 | $154.54M(-6.0%) | $19.00K(-100.0%) | $154.54M(-0.5%) |
Sep 2020 | - | $142.52M(+1152.2%) | $155.28M(+1093.9%) |
Jun 2020 | - | $11.38M(+1753.7%) | $13.01M(+786.6%) |
Mar 2020 | - | $614.00K(-18.9%) | $1.47M(-99.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2019 | $164.40M(+152.6%) | $757.00K(+199.2%) | $164.40M(+0.1%) |
Sep 2019 | - | $253.00K(-261.1%) | $164.29M(-0.7%) |
Jun 2019 | - | -$157.00K(-100.1%) | $165.39M(-27.2%) |
Mar 2019 | - | $163.55M(>+9900.0%) | $227.10M(+248.9%) |
Dec 2018 | $65.09M(-31.0%) | $646.00K(-52.2%) | $65.09M(+0.1%) |
Sep 2018 | - | $1.35M(-97.8%) | $65.04M(+2.0%) |
Jun 2018 | - | $61.56M(+3905.2%) | $63.74M(-33.4%) |
Mar 2018 | - | $1.54M(+161.0%) | $95.72M(+1.4%) |
Dec 2017 | $94.37M(+224.1%) | $589.00K(+898.3%) | $94.37M(+0.6%) |
Sep 2017 | - | $59.00K(-99.9%) | $93.80M(-0.1%) |
Jun 2017 | - | $93.54M(>+9900.0%) | $93.92M(+220.3%) |
Mar 2017 | - | $190.00K(+1166.7%) | $29.33M(+0.7%) |
Dec 2016 | $29.12M(-83.4%) | $15.00K(-91.8%) | $29.12M(-77.9%) |
Sep 2016 | - | $184.00K(-99.4%) | $131.84M(-31.6%) |
Jun 2016 | - | $28.94M(<-9900.0%) | $192.87M(+17.6%) |
Mar 2016 | - | -$16.00K(-100.0%) | $163.95M(-6.6%) |
Dec 2015 | $175.59M(+3025.0%) | $102.74M(+67.8%) | $175.59M(+141.0%) |
Sep 2015 | - | $61.21M(>+9900.0%) | $72.86M(+525.6%) |
Jun 2015 | - | $15.00K(-99.9%) | $11.65M(+0.1%) |
Mar 2015 | - | $11.63M | $11.63M |
Dec 2014 | $5.62M(+53.0%) | - | - |
Dec 2013 | $3.67M | - | - |
FAQ
- What is Wave Life Sciences Ltd. annual cash flow from financing activities?
- What is the all time high annual CFF for Wave Life Sciences Ltd.?
- What is Wave Life Sciences Ltd. annual CFF year-on-year change?
- What is Wave Life Sciences Ltd. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Wave Life Sciences Ltd.?
- What is Wave Life Sciences Ltd. quarterly CFF year-on-year change?
- What is Wave Life Sciences Ltd. TTM cash flow from financing activities?
- What is the all time high TTM CFF for Wave Life Sciences Ltd.?
- What is Wave Life Sciences Ltd. TTM CFF year-on-year change?
What is Wave Life Sciences Ltd. annual cash flow from financing activities?
The current annual CFF of WVE is $253.89M
What is the all time high annual CFF for Wave Life Sciences Ltd.?
Wave Life Sciences Ltd. all-time high annual cash flow from financing activities is $253.89M
What is Wave Life Sciences Ltd. annual CFF year-on-year change?
Over the past year, WVE annual cash flow from financing activities has changed by +$121.36M (+91.57%)
What is Wave Life Sciences Ltd. quarterly cash flow from financing activities?
The current quarterly CFF of WVE is $4.16M
What is the all time high quarterly CFF for Wave Life Sciences Ltd.?
Wave Life Sciences Ltd. all-time high quarterly cash flow from financing activities is $203.75M
What is Wave Life Sciences Ltd. quarterly CFF year-on-year change?
Over the past year, WVE quarterly cash flow from financing activities has changed by -$10.36M (-71.36%)
What is Wave Life Sciences Ltd. TTM cash flow from financing activities?
The current TTM CFF of WVE is $243.53M
What is the all time high TTM CFF for Wave Life Sciences Ltd.?
Wave Life Sciences Ltd. all-time high TTM cash flow from financing activities is $312.87M
What is Wave Life Sciences Ltd. TTM CFF year-on-year change?
Over the past year, WVE TTM cash flow from financing activities has changed by +$131.54M (+117.46%)